Crossref
Novel Immunotherapies for Neurodegenerative Diseases
EU Research · 2024
DOI: 10.56181//izyf6136 ↗Kurz gefasst
Fachartikel in der Zeitschrift EU Research, 2024. Verfasst von Bob Harris.
Abstract (Originalsprache)
What drives the progression of neurodegenerative diseases like ALS, Alzheimer’s, and MS? Unraveling the mechanisms of neuroinflammation is at the heart of Prof. Bob Harris’s research at the Karolinska Institutet. His team is pioneering new therapeutic approaches by targeting microglial activity and harnessing advanced stem cell techniques. Their goal is to transform treatment strategies for these debilitating conditions.
Zitieren
APA
Harris, B. (2024). Novel Immunotherapies for Neurodegenerative Diseases. EU Research. https://doi.org/10.56181//izyf6136
Vancouver
Harris B. Novel Immunotherapies for Neurodegenerative Diseases. EU Research. 2024. doi:10.56181//izyf6136
BibTeX
@article{Harris2024,
author = {Harris, Bob},
title = {Novel Immunotherapies for Neurodegenerative Diseases},
journal = {EU Research},
year = {2024},
doi = {10.56181//izyf6136}
}
EUVIMED